Australia's Allegra Orthopaedics climbs on progress on spinal cage device

Allegra Medical Technologies

21/12/2020 24:36

** Shares of Allegra Orthopaedics Ltd  AMT.AX  climb as much
as 50% to A$0.465, their highest since Dec. 4 
    ** Orthopaedic products maker says that its flagship spinal
cage device, Sr–HT–Gahnite, a 3D-printed synthetic bone-graft
medical device which has potential to support bone regeneration,
has passed the required 5 million cycles without any signs of
fracture or failure  urn:newsml:reuters.com:*:nASXbsjp3q
    ** AMT remains on track to commence pilot animal study with
a new spinal cage design in Jan. 2021, in Australia
    ** Stock posts its biggest intraday pct gain since Dec. 4
    ** More than 511,000 shares change hands vs the 30-day
average volume of 201,000 shares
    ** Stock is up 55% this year, as of last close

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))